Assessment of cost of illness for diabetic patients in South Indian tertiary care hospital

Abstract

Background:The impact of diabetes on health-care expenditures has been increasingly recognized. To formulate an effective health planning and resource allocation, it is important to determine economic burden.Objective:The objective of this study is to assess the cost of illness (COI) for diabetic inpatients with or without complications.Methodology:The study was conducted in the medicine wards of tertiary care hospital after ethical approval by the Institutional Ethical Committee. A total of 116 each diabetic with or without complications were selected and relevant data were collected using COI questionnaire and data were analyzed using SPSS version 20. Mann–Whitney U test is used to assess the statistical significant difference in the cost of treatment of diabetes alone and with complications’. P ≤ 0.05 was considered statistically significant.Results:Total COI includes the cost of treatment, investigation, consultation fee, intervention cost, transportation, days lost due to work, and hospitalization. The median of total COI for diabetic care without any complication was Rs. 22,456.97/- per patient per annum and with complication was Rs. 30,634.45/-. Patients on dialysis had to spend 7.3 times higher, and patients with cardiac intervention had to spend 7.4 times higher than diabetic patients without any complication.Conclusion:Treatment costs were many times higher in patients with complications and with cardiac and renal interventions. Complications in diabetic patients will increase the economic burden to family and also to the society.

A Pharmacoeconomic Study and Its Appraisal in Improving Health Care Outcomes in Patients Suffering From Type-2 Diabetes Among Rural Areas in South-East India.

“…This finding was in concordance with the study done by Leelavathi D, et al, [20] (2017) on Assessment of cost of illness for diabetic patients in South Indian tertiary care hospital which stated that cost of illness is comparatively high in patients with complications than Diabetes alone Similarly literature stated that macrovascular comorbid conditions are a major driver of health care costs in patients with diabetes, including both increased direct health care cost and lost indirect productivity cost.…”

Patterns and determinants of health care spending in denizens of urban slums from peri-industrial area of Hyderabad

“…[5][6][7] It was observed that, though majority of the study participants were belonging to lower socio economic class (class 1 and 2 of BG Prasad's classification of socio economic stratification), only, one third of the participants were covered by one of the (33.18%) social security scheme for health insurance. Rest two thirds of the population was forced to spend out of pocket.…”

Healthcare utilisation and out-of-pocket expenditure of type 2 diabetes patients with and without comorbidity: A study in primary care in Bhubaneswar, India.

“…[27] Acharya et al assessed the costs of illness for diabetes patients with or without complications hospitalized in a tertiary care hospital; they concluded that diabetes patients with renal and cardiac complications incurred greater expenses than those with other chronic complications. [28] These studies only investigated the cost of concordant comorbidities and complications associated with diabetes. As our study has taken into account both concordant and discordant comorbidities, comparability to these studies is limited.…”